These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17593033)

  • 1. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
    Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
    Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
    Hamad Z; Aljedai A; Halwani R; AlSultan A
    Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
    Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
    BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
    Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
    Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.
    Martins R; Morais A; Dias A; Soares I; Rolão C; Ducla-Soares JL; Braga L; Seixas T; Nunes B; Olim G; Romão L; Lavinha J; Faustino P
    J Hum Genet; 2008; 53(6):524-528. PubMed ID: 18392554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
    de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
    Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
    Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
    Chaar V; Kéclard L; Etienne-Julan M; Diara JP; Elion J; Krishnamoorthy R; Romana M
    Am J Hematol; 2006 May; 81(5):377-9. PubMed ID: 16628735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
    Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
    Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer.
    Jirásková A; Novotný J; Novotný L; Vodicka P; Pardini B; Naccarati A; Schwertner HA; Hubácek JA; Puncochárová L; Šmerhovský Z; Vítek L
    Int J Cancer; 2012 Oct; 131(7):1549-55. PubMed ID: 22212955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UGT1A1 variation and gallstone formation in sickle cell disease.
    Haverfield EV; McKenzie CA; Forrester T; Bouzekri N; Harding R; Serjeant G; Walker T; Peto TE; Ward R; Weatherall DJ
    Blood; 2005 Feb; 105(3):968-72. PubMed ID: 15388579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.
    Lin R; Wang X; Wang Y; Zhang F; Wang Y; Fu W; Yu T; Li S; Xiong M; Huang W; Jin L
    Hum Mutat; 2009 Apr; 30(4):609-15. PubMed ID: 19243019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGT1A1 (TA)
    Joly P; Renoux C; Lacan P; Bertrand Y; Cannas G; Garnier N; Cuzzubbo D; Kebaïli K; Renard C; Gauthier A; Pialoux V; Martin C; Romana M; Connes P
    Eur J Haematol; 2017 Mar; 98(3):296-301. PubMed ID: 27981643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do UGT1A1 and HMOX1 gene promoter polymorphisms increase the risk of hyperbilirubinemia and gallstones in patients with hereditary spherocytosis?
    Warang P; Devendra R; D'Silva S; Chiddarwar A; Kedar P; Ghosh K; Colah R; Mukherjee MB
    Ann Hematol; 2015 Jan; 94(1):169-71. PubMed ID: 24947795
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum Bilirubin Levels and Promoter Variations in
    Jirásková A; Bortolussi G; Dostálová G; Eremiášová L; Golaň L; Danzig V; Linhart A; Vítek L
    Oxid Med Cell Longev; 2017; 2017():9478946. PubMed ID: 28951772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C.
    Urbánek P; Leníček M; Muchová L; Subhanová I; Dušek L; Kaspříková N; Hrabal P; Bruha R; Vítek L
    Ann Hepatol; 2011; 10(4):445-51. PubMed ID: 21911884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.